In addition to alterations to Aβ processing, perturbations to the transcription factor nuclear factor kappa b (NF-κB) have been consistently reported in AD [10], although inconsistencies exist regarding the direction and magnitude of these alterations. The gene discussed is NFKB1; the disease is Alzheimer disease.